PHILADELPHIA, PA / ACCESS Newswire / January 28, 2026 / Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Neogen Corporation (NASDAQ:NEOG) ("Neogen") on behalf of the company’s long-term shareholders.
Click here to submit your information to the firm and to receive additional information about your legal rights and options: https://kaskelalaw.com/case/neogen/
Recently a federal securities fraud complaint was filed against Neogen on behalf of certain investors who purchased shares of the company’s stock between January 5, 2023 through June 3, 2025 (the "Relevant Period"). According to the complaint, during the Relevant Period, Neogen and certain of the company’s senior executive officers issued a series of materially false and misleading statements to investors about Neogen’s business and operations, including the company’s progress integrating the Food Safety Division of the 3M Company ("3M"). Specifically, defendants are alleged to have (i) failed to disclose the true state of the 3M integration, which led investors to believe that the 3M integration was going better than it was; and (ii) downplayed certain inefficiencies that arose as a result of the integration with 3M.
As further detailed in the complaint, through a series of partial disclosures made to investors between April 2024 and June 2025, shares of Neogen’s common stock significantly declined in value as investors learned the true state of the failing 3M integration, and its negative financial and operational impact on the company’s results.
In light of the foregoing, Kaskela Law is investigating whether Neogen’s officers and directors violated the securities laws and/or breached their fiduciary duties in connection with the above alleged misconduct.
Current Neogen shareholders who have continuously held NEOG shares since at least April 9, 2024 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) to receive additional information about this investigation and their legal rights and options at (484) 229 – 0750, via email at abell@kaskelalaw.com, or by clicking on the following link (or if necessary, by copying and pasting the link into your browser):
https://kaskelalaw.com/case/neogen/
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis, and has assisted investors in recovering over $500 million. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com
This notice may constitute attorney advertising in certain jurisdictions.
SOURCE: Kaskela Law LLC
View the original press release on ACCESS Newswire
COMTEX_472506153/2457/2026-01-28T07:59:25